Global DNA Hypermethylation in Down Syndrome Placenta

English version České info

Down syndrome (DS), commonly caused by an extra copy of chromosome 21 (chr21), occurs in approximately one out of 700 live births. Precisely how an extra chr21 causes over 80 clinically defined phenotypes is not yet clear. Reduced representation bisulfite sequencing (RRBS) analysis at single base resolution revealed DNA hypermethylation in all autosomes in DS samples. We hypothesize that such global hypermethylation may be mediated by down-regulation of TET family genes involved in DNA demethylation, and down-regulation of REST/NRSF involved in transcriptional and epigenetic regulation. Genes located on chr21 were up-regulated by an average of 53% in DS compared to normal villi, while genes with promoter hypermethylation were modestly down-regulated. DNA methylation perturbation was conserved in DS placenta villi and in adult DS peripheral blood leukocytes, and enriched for genes known to be causally associated with DS phenotypes. Our data suggest that global epigenetic changes may occur early in development and contribute to DS phenotypes.

Vyšlo v časopise: Global DNA Hypermethylation in Down Syndrome Placenta. PLoS Genet 9(6): e32767. doi:10.1371/journal.pgen.1003515
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003515

Souhrn

Zdroje

1. Deitz SL, Blazek JD, Solzak JP, Roper RJ (2011) Down Syndrome: A Complex and Interactive Genetic Disorder. Rijeka, Croatia: InTech.

2. KahlemP, SultanM, HerwigR, SteinfathM, BalzereitD, et al. (2004) Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. Genome Res 14: 1258–1267.

3. LyleR, GehrigC, Neergaard-HenrichsenC, DeutschS, AntonarakisSE (2004) Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. Genome Res 14: 1268–1274.

4. MaoR, ZielkeCL, ZielkeHR, PevsnerJ (2003) Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81: 457–467.

5. FitzPatrickDR, RamsayJ, McGillNI, ShadeM, CarothersAD, et al. (2002) Transcriptome analysis of human autosomal trisomy. Hum Mol Genet 11: 3249–3256.

6. CostaV, AngeliniC, D'ApiceL, MutarelliM, CasamassimiA, et al. (2011) Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One 6: e18493.

7. RozovskiU, Jonish-GrossmanA, Bar-ShiraA, OchshornY, GoldsteinM, et al. (2007) Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod 22: 2538–2545.

8. FengJ, ZhouY, CampbellSL, LeT, LiE, et al. (2010) Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13: 423–430.

9. GuoJU, SuY, ZhongC, MingGL, SongH (2011) Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145: 423–434.

10. Sanchez-Mut JV, Huertas D, Esteller M (2012) Aberrant epigenetic landscape in intellectual disability. New York, NY: Elsevier.

11. AmirRE, Van den VeyverIB, WanM, TranCQ, FranckeU, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188.

12. VeldicM, GuidottiA, MalokuE, DavisJM, CostaE (2005) In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 102: 2152–2157.

13. ParkJ, SongWJ, ChungKC (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci 66: 3235–3240.

14. PogribnaM, MelnykS, PogribnyI, ChangoA, YiP, et al. (2001) Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69: 88–95.

15. ChimSS, JinS, LeeTY, LunFM, LeeWS, et al. (2008) Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 54: 500–511.

16. PapageorgiouEA, FieglerH, RakyanV, BeckS, HultenM, et al. (2009) Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 174: 1609–1618.

17. ChuT, BurkeB, BunceK, SurtiU, Allen HoggeW, et al. (2009) A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 29: 1020–1030.

18. Eckmann-ScholzC, BensS, KolarovaJ, SchneppenheimS, CaliebeA, et al. (2012) DNA-Methylation Profiling of Fetal Tissues Reveals Marked Epigenetic Differences between Chorionic and Amniotic Samples. PLoS One 7: e39014.

19. MeyerLR, ZweigAS, HinrichsAS, KarolchikD, KuhnRM, et al. (2013) The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 41: D64–69.

20. ZhangY, RohdeC, TierlingS, JurkowskiTP, BockC, et al. (2009) DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet 5: e1000438.

21. EckhardtF, LewinJ, CorteseR, RakyanVK, AttwoodJ, et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38: 1378–1385.

22. LaurentL, WongE, LiG, HuynhT, TsirigosA, et al. Dynamic changes in the human methylome during differentiation. Genome Res 20: 320–331.

23. ListerR, PelizzolaM, DowenRH, HawkinsRD, HonG, et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315–322.

24. StadlerMB, MurrR, BurgerL, IvanekR, LienertF, et al. (2011) DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480: 490–495.

25. MeissnerA, MikkelsenTS, GuH, WernigM, HannaJ, et al. (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766–770.

26. JaffeAE, FeinbergAP, IrizarryRA, LeekJT (2012) Significance analysis and statistical dissection of variably methylated regions. Biostatistics 13: 166–178.

27. KerkelK, SchupfN, HattaK, PangD, SalasM, et al. Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet 6: e1001212.

28. TahilianiM, KohKP, ShenY, PastorWA, BandukwalaH, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930–935.

29. HeYF, LiBZ, LiZ, LiuP, WangY, et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303–1307.

30. ItoS, ShenL, DaiQ, WuSC, CollinsLB, et al. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300–1303.

31. FiczG, BrancoMR, SeisenbergerS, SantosF, KruegerF, et al. (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398–402.

32. DawlatyMM, GanzK, PowellBE, HuYC, MarkoulakiS, et al. (2011) Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9: 166–175.

33. HewittCA, LingKH, MersonTD, SimpsonKM, RitchieME, et al. (2010) Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome. PLoS One 5: e11561.

34. GuidiS, BonasoniP, CeccarelliC, SantiniD, GualtieriF, et al. (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 18: 180–197.

35. ContestabileA, FilaT, CeccarelliC, BonasoniP, BonapaceL, et al. (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17: 665–678.

36. ChakrabartiL, BestTK, CramerNP, CarneyRS, IsaacJT, et al. (2010) Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci 13: 927–934.

37. Lepagnol-BestelAM, ZvaraA, MaussionG, QuignonF, NgimbousB, et al. (2009) DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum Mol Genet 18: 1405–1414.

38. YuM, HonGC, SzulwachKE, SongCX, ZhangL, et al. (2012) Base-resolution analysis of 5-hydroxymethylcytosine in the Mammalian genome. Cell 149: 1368–1380.

39. NisiharaRM, UtiyamaSR, OliveiraNP, Messias-ReasonIJ (2010) Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down's syndrome. Hum Immunol 71: 63–66.

40. BithellA (2011) REST: transcriptional and epigenetic regulator. Epigenomics 3: 47–58.

41. BahnS, MimmackM, RyanM, CaldwellMA, JauniauxE, et al. (2002) Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet 359: 310–315.

42. CanzonettaC, MulliganC, DeutschS, RufS, O'DohertyA, et al. (2008) DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome. Am J Hum Genet 83: 388–400.

43. NovakovicB, YuenRK, GordonL, PenaherreraMS, SharkeyA, et al. (2011) Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics 12: 529.

44. KorbelJO, Tirosh-WagnerT, UrbanAE, ChenXN, KasowskiM, et al. (2009) The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A 106: 12031–12036.

45. LyleR, BenaF, GagosS, GehrigC, LopezG, et al. (2009) Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet 17: 454–466.

46. CostaAC (2011) On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome. Dev Neurosci 33: 414–427.

47. BartesaghiR, GuidiS, CianiE (2011) Is it possible to improve neurodevelopmental abnormalities in Down syndrome? Rev Neurosci 22: 419–455.

48. LangmeadB, TrapnellC, PopM, SalzbergSL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.